Compare ELTX & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | HIT |
|---|---|---|
| Founded | 2011 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 74.1M |
| IPO Year | 2014 | 2024 |
| Metric | ELTX | HIT |
|---|---|---|
| Price | $2.18 | $0.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $18.00 | $3.25 |
| AVG Volume (30 Days) | ★ 266.2K | 71.2K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 39.29 | ★ 100.00 |
| EPS | N/A | ★ N/A |
| Revenue | $2,301,000.00 | ★ $33,327,511.00 |
| Revenue This Year | N/A | $41.00 |
| Revenue Next Year | N/A | $69.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 70.99 |
| 52 Week Low | $2.34 | $0.85 |
| 52 Week High | $16.00 | $4.01 |
| Indicator | ELTX | HIT |
|---|---|---|
| Relative Strength Index (RSI) | 24.01 | 37.29 |
| Support Level | N/A | $0.93 |
| Resistance Level | $3.32 | $1.15 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 1.09 | 9.44 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.